{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "Heparin",
      "Neutrophils",
      "Polyanions",
      "Polycations",
      "SARS-CoV-2",
      "Therapy"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33412501",
  "DateCompleted": {
    "Year": "2021",
    "Month": "02",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "01",
        "Day": "04"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.mehy.2020.110470",
      "S0306-9877(20)33361-2"
    ],
    "Journal": {
      "ISSN": "1532-2777",
      "JournalIssue": {
        "Volume": "146",
        "PubDate": {
          "Year": "2021",
          "Month": "Jan"
        }
      },
      "Title": "Medical hypotheses",
      "ISOAbbreviation": "Med Hypotheses"
    },
    "ArticleTitle": "Polycations and polyanions in SARS-CoV-2 infection.",
    "Pagination": {
      "StartPage": "110470",
      "MedlinePgn": "110470"
    },
    "Abstract": {
      "AbstractText": [
        "We hypothesize that polycations, such as nuclear histones, released by neutrophils COVID-19 aggravate COVID-19 by multiple mechanisms: (A) Neutralization of the electrostatic repulsion between the virus particles and the cell membrane, thereby enhancing receptor-mediated entry. (B) Binding to the virus particles, thereby inducing opsonin-mediated endocytosis. (C) Adding to the cytotoxicity, in conjunction with oxidants, cytokines and other pro-inflammatory substances secreted by cells of the innate immunity system. These effects may be alleviated by the administration of negatively charged polyanions such as heparins and heparinoids."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021 The Authors. Published by Elsevier Ltd.. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "The Hebrew University - Hadassah School of Medicine, The Faculty of Dental Medicine, The Ein-Kerm Campus, Jerusalem, Israel."
          }
        ],
        "LastName": "Ginsburg",
        "ForeName": "I",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "The Hebrew University - Hadassah School of Medicine, Department of Hematology, The Ein-Kerm Campus, Jerusalem, Israel. Electronic address: Fibach@yahoo.com."
          }
        ],
        "LastName": "Fibach",
        "ForeName": "E",
        "Initials": "E"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Med Hypotheses",
    "NlmUniqueID": "7505668",
    "ISSNLinking": "0306-9877"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Histones"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Polyelectrolytes"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "polyanions"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "polycations"
    },
    {
      "RegistryNumber": "9005-49-6",
      "NameOfSubstance": "Heparin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "etiology",
        "metabolism"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Endocytosis"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Heparin"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Histones"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunity, Innate"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Models, Biological"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Neutrophils"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "metabolism",
        "therapeutic use"
      ],
      "DescriptorName": "Polyelectrolytes"
    },
    {
      "QualifierName": [
        "drug effects",
        "pathogenicity",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Static Electricity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Virus Internalization"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ],
  "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."
}